Introduction {#S0001}
============

Bloodstream infections are serious, life-threatening infections that are associated with significant healthcare costs and poor patient prognoses.[@CIT0001],[@CIT0002] *Klebsiella pneumoniae* is one of the common Gram-negative bacteria in the community and it causes various types of infections.[@CIT0003] However, an international collaborative study indicated the geographic differences in clinical manifestations.[@CIT0004] Notably in Asia, as a second leading pathogen in community-onset bacteremia,[@CIT0004] a new invasive syndrome consisting of hepatic abscesses, frequently accompanied by metastatic infections with abscess occurrences elsewhere, has globally emerged as a substantial public health problem in the community.[@CIT0005],[@CIT0006]

Dissimilar to classical *K. pneumoniae*, a new variant of hypermucoviscous *K. pneumoniae* was described due to its predominant ability to develop pyogenic hepatic abscesses and septic metastasis, even in apparently healthy adults.[@CIT0007] Adequate or rapid drainage has been recommended to treat this invasive syndrome and to achieve a better clinical response.[@CIT0006],[@CIT0008] Several patient characteristics, such as the comorbidity of diabetes mellitus or alcoholism, contribute to the invasive syndrome; notably, the strongest predictors of septic metastasis are by far isolates with a hypermucoviscosity (HMV) phenotype and capsular K1 serotype.[@CIT0005],[@CIT0006],[@CIT0009] However, these study populations were all limited to patients with hepatic abscesses and were not representative of all patients infected by *K. pneumoniae*. Moreover, the effect of HMV on the occurrence of hepatic or extra-hepatic abscesses among patients with bloodstream infections remains unclear. For patients with *K. pneumoniae* bacteremia, it is clinically beneficial to identify which patients are at increased risk of developing abscesses and need timely imaging studies and further surgical or drainage intervention. Thus, we aimed to integrate HMV-related factors into developing a scoring algorithm that can be simply and accurately applied to aid the clinician for early identifying patients at greater risk for the abscess occurrence and further to analyze the impact of HMV-related factors on patient prognoses.

Methods {#S0002}
=======

Study Design {#S0002-S2001}
------------

This 4-year cohort study was retrospectively conducted at an emergency department (ED) of a university-affiliated hospital in southern Taiwan during the period between January 2012 and December 2015. During the study period, adults with monomicrobial *K. pneumoniae* bacteremia in the ED were studied. Their medical records were retrospectively reviewed for capturing clinical information, in terms of sources of transfer, vital signs, bacteremia severity, comorbidity types, laboratory data, and initial sepsis-related syndrome, immediately following each ED visit. Furthermore, records of prior hospitalization, immunosuppressive agents or chemotherapy received prior to the ED visit, durations and types of antimicrobial administration, imaging studies, bacteremia sources, the length of the hospital stay, and patient outcomes were assessed from the chart records.

The exclusion criteria were patients lacking clinical information prior to the study endpoint when chart reviewing, those experienced the hospital transfer prior to ED visits (ie, uncertain sites of bacteremia onset), those with hospital-onset bloodstream infections, and those lacking the comprehensive imaging studies (ie, chest X-ray plus either abdominal computed tomography \[CT\] or sonography). Moreover, for patients categorized in the non-abscess group, a follow-up of at least 90 days after the bacteremia onset was conducted to ensure that there was no recurrence of *K. pneumoniae* bacteremia or abscesses; those not followed during this period were excluded. All medical records were reviewed by random two of the authors, and the records were discussed by the two authors if any discrepancy was discovered. The primary endpoint was Day 28 after the bacteremia onset (ie, ED arrival) for overall patients and the secondary endpoint was Day 90 after bacteremia onset for patients in the non-abscess group.

Microbiological Methods {#S0002-S2002}
-----------------------

*K. pneumoniae* was identified by biochemical tests and then confirmed using a Vitek system (BioMe'rieux, France) by the Gram-negative-identification card. The susceptibility of antibiotics was determined using the disc diffuse method, and the interpretation followed the contemporary breakpoint recommended by the Clinical and Laboratory Standards Institute.[@CIT0010] ESBL production was detected by the phenotypic confirmatory test with the cephalosporin-clavulanate combination disks.[@CIT0011]

Detection of HMV Genotype and Phenotype {#S0002-S2003}
---------------------------------------

The HMV phenotype and HMV-related genotype (ie, *mag*A and *rmp*A) were assessed for *K. pneumoniae* isolated from eligible bacteremia patients. To assess the HMV phenotype, a bacteriologic loop was used to stretch a mucoviscous string from the colony; the formation of the strings of \>5 mm in length was defined as a positive string test result, as previously reported.[@CIT0005] To detect the chromosome-mediated mucoviscosity-associated gene A *(mag*A) and mucoid phenotype A (*rmpA*) genes, PCR was performed using previously described PCR primers and conditions, with genomic DNA or plasmid DNA as the template, respectively.[@CIT0009]

Definitions {#S0002-S2004}
-----------

Bacteremia was defined as bacterial growth of blood cultures drawn from central or peripheral venipuncture, after exclusion of contaminant sampling. Blood culture sampling with potentially contaminating pathogens, such as coagulase-negative staphylococci, *Micrococcus* species, *Bacillus* species, *Propionibacterium* species, and Gram-positive bacilli, were considered to be contaminated based on previously established criteria.[@CIT0012] Community-onset bacteremia indicates that the place of the bacteremia onset is inside the community and includes community-acquired and long-term healthcare facility-acquired bloodstream infections.[@CIT0013],[@CIT0014] Patients were assigned to the abscess group if the bacteremic episode occurred in conjunction with hepatic and/or extra-hepatic abscesses that were diagnosed by imaging and microbiological studies. As previously described,[@CIT0014],[@CIT0015] the virulence gene *mag*A and the surrounding 33-kb genomic region was demonstrated to be the genetic determinant of capsular serotype K1. As previous description,[@CIT0016] appropriate antimicrobial administration was defined as antimicrobial therapy to which the isolated *K. pneumoniae* was susceptible in vitro and in which the dosage and route of antimicrobial administration was in accordance with the Sanford Guide.[@CIT0017] Bacteremia severity was graded using a Pitt bacteremia score, which was a validated score based on vital signs, mental status, receipt of mechanical ventilation, vasopressor agent use, and recent cardiac arrest.[@CIT0014],[@CIT0016] Hematological malignancies and solid tumors were grouped as malignancies, while comorbidities were defined as previously described.[@CIT0018] The comorbidity severity was assessed by a delineated McCabe classification, in which comorbidities were categorized as the rapid fatal, ultimately fatal, and non-fatal groups.[@CIT0019] The clinical categorization of the sources of bacteremic episodes followed the published definitions from the Centers for Disease Control and Prevention.[@CIT0020] The death by all causes was regarded as crude mortality.

Statistical Analysis {#S0002-S2005}
--------------------

The Statistical Package for the Social Sciences for Windows (Chicago, Illinois, USA, Version 23.0) was tested for statistical analyses. Continuous and categorical variables were compared using Student's *t* and Chi-square (or Fisher's exact) tests, respectively. To recognized independent predictors of abscess occurrences, all variables with *P* values of \<0.1 recognized by univariate analyses were included for the stepwise, backward logistic regression model. Furthermore, to identify the independent predictor of 28-day mortality and further investigate the impact of HMV factors or abscess occurrences on 28-day mortality, all variables with *P* values of \<0.1, recognized by univariate analyses, and HMV factors were together processing under the model of hierarchical logistic regression. The curve of receiver operating characteristic (ROC) was performed to estimate the accuracy of a prediction tool.[@CIT0021] A *P* value of \<0.05 was considered significant.

Results {#S0003}
=======

Patient Population {#S0003-S2001}
------------------

The 4-year cohort consisting of 287 bacteremic adults of community-onset monomicrobial *K. pneumoniae* was conducted. After exclusion of 29 cases, 258 adults were included in the present study ([Figure 1](#F0001){ref-type="fig"}). Of the 258 patients, only 79 (30.6%) had abscesses; the distributions of the various abscess types are shown in [Figure 1](#F0001){ref-type="fig"}. Of the 179 patients without abscesses, none were excluded due to incomplete follow-up within 90 days of the onset of bacteremia, and none displayed a recurrence of *K. pneumoniae* bacteremia or abscesses during those 90 days. The major comorbidities of the total 258 patients included diabetes mellitus (109 patients, 42.2%), hypertension (106, 41.1%), malignancies (81, 31.4%), neurological disorders (61, 23.6%), liver cirrhosis (48, 18.8%), chronic kidney diseases (37, 14.3%), coronary artery diseases (26, 10.1%), and chronic obstructive pulmonary diseases (21, 8.1%).Figure 1Schematic flow chart.

Because four patients had multiple foci of infections, 184 portals of entry were disclosed among the 179 patients in the non-abscess group. The leading source of bacteremia was the respiratory tract infection (48 patients, 25.8%), followed by the urinary tract (42, 23.5%), primary bacteremia (30, 16.8%), the biliary tract (29, 16.2%), intra-abdominal (23, 12.8%), vascular catheter-related (6, 3.4%), bone and joint (3, 1.7%), endocarditis (2, 1.1%), the central nervous system (2, 1.1%), and skin and soft-tissue (1, 0.6%). Of 81 abscess forms among 79 patients in the abscess group, the leading was liver abscesses (50 patients, 63.3%), followed by 8 patients (10.1%) with respiratory tract abscesses (6 with lung abscesses, 2 with empyema), 8 (10.1%) with soft-tissue abscesses (4 with pyomyositis, 2 with psoas muscle abscesses, 1 with a perianal abscess, and 1 with a deep neck abscess), 7 (8.9%) with renal abscesses, 3 (3.8%) with epidural abscesses, 2 (2.5%) with cholangeal abscesses, 2 (2.5%) with peritoneal abscesses, and 1 (1.2%) with mycotic aneurysm.

Of the total 258 *K. pneumoniae*, the susceptibility rate to cefepime was the highest (250 isolates, 96.9%), followed by cefotaxime (240, 93.0%), levofloxacin (237, 91.9%), cefuroxime (228, 88.4%), ampicillin/sulbactam (221, 85.7%), and cefazolin (192, 74.4%). Notably, ESBL-producers only accounted for 5.8% (15 isolates) of *K. pneumoniae* isolated in the overall cohort.

Predictors of Abscesses {#S0003-S2002}
-----------------------

The following predictors were significantly associated with abscesses in univariate analyses ([Table 1](#T0001){ref-type="table"}): old age, recent chemotherapy, severe comorbidities, malignancies, chronic kidney disease, a low platelet count, a high C-reactive protein (CRP) level, or a high serum creatinine level at bacteremia onset. Of note, a strong relationship between the HMV phenotype or genotype (ie, *rmp*A and *mag*A) and abscesses was discovered ([Figure 2A](#F0002){ref-type="fig"}). Additionally, *K. pneumoniae* with the HMV phenotype or genotype was more frequently observed in patients having liver abscesses, compared to those with extra-hepatic abscesses ([Figure 2B](#F0002){ref-type="fig"}).Table 1Clinical Characteristics of Adults with Community-Onset Monomicrobial *K. pneumoniae* Bacteremia, Categorized by the Presence or Absence of AbscessesCharacteristicsPatient Number (%)*P* valuesAbscess, n=79Non-Abscess, n=179Old age (≥65 years)39 (49.4)113 (63.1)0.04Male gender58 (73.4)111 (62.0)0.08Nursing home residents2 (2.5)9 (5.0)0.51Events During the Previous 4 Weeks Prior hospitalization16 (20.3)55 (30.7)0.08 Surgery4 (5.1)6 (3.4)0.55 Immunosuppression2 (2.5)1 (0.6)0.22 Steroid therapy3 (3.8)5 (2.8)0.70 Chemotherapy0 (0)19 (10.6)0.003 Invasive procedure1 (1.3)5 (2.8)0.67Severity of Sepsis at Bacteremia Onset Pitt bacteremia score ≥4 points17 (21.5)49 (27.4)0.32 Admitted to intensive care units18 (22.8)39 (21.8)0.86 Severe sepsis44 (55.7)90 (50.3)0.42 Septic shock19 (24.1)50 (27.9)0.52Severity of Underlying Disease (McCabe Classification)0.03 Rapidly or ultimately fatal16 (20.3)60 (33.5) Non-fatal63 (79.7)119 (66.5)Major Comorbidity Diabetes mellitus40 (50.6)69 (38.5)0.07 Hypertension28 (21.5)78 (43.6)0.22 Malignancy17 (21.5)64 (35.5)0.02 Neurological disorder13 (13.9)48 (26.8)0.07 Liver cirrhosis11 (13.9)38 (21.2)0.17 Coronary artery disease7 (8.9)19 (10.6)0.66 Chronic kidney disease6 (7.6)31 (17.3)0.04 Urological disease6 (7.6)13 (7.3)0.93 Chronic obstructive pulmonary diseases5 (6.3)16 (8.9)0.48Laboratory Data at Bacteremic Onset^a^ Leukocytes \>9000/mm^3^51 (64.6)108 (60.3)0.52 Platelets \<150,000/mm^3^45 (57.0)74 (41.3)0.02 Blood urea nitrogen \>20 mg/dL39/72 (54.2)96/171 (56.1)0.78 Serum creatinine \>1.5 mg/dL17 (21.5)66 (36.9)0.02 C-reactive protein \>100 mg/L63 (79.7)62 (34.6)\<0.001[^1] Figure 2Microbiological characteristics of *K. pneumoniae* isolates causing community-onset bacteremia with or without abscesses (**A**) and with a hepatic abscess or extra-hepatic abscess (**B**).**Abbreviation:** HMV, hypermucoviscosity.

However, when the variables with *P*\<0.1, recognized by the univariate analysis ([Table 1](#T0001){ref-type="table"}), and HMV phenotype or genotype (as shown in [Figure 2A](#F0002){ref-type="fig"}) were together assessed by the multivariate regression model, only seven variables were independently linked to abscess occurrences ([Table 2](#T0002){ref-type="table"}): male gender, the HMV phenotype, the presence of *mag*A (ie, capsular serotype K1), recent chemotherapy, the comorbidity with neurological disorder or diabetes mellitus, and a high CRP level at bacteremia onset. Notably, the presence of the HMV phenotype and capsular K1 serotype was by far the most powerful predictors of abscess formation; the association of abscess occurrences and *rmp*A was not significant under the multivariate regression model.Table 2Multivariate Analysis of Risk Factors for Abscess Formation Among Community-Onset Monomicrobial *K. pneumoniae* BacteremiaVariablesAdjusted OR\
(95% C.I.)P valueCoKPBASModel 1Model 2^a^Model 3^b^Gender, male2.21 (1.02--4.78)0.04111HMV phenotype3.17 (1.56--6.43)0.00111--Capsular K1 serotype (*magA-*harboring isolates)4.00 (1.92--8.36)\<0.0011\--Recent chemotherapy0.22 (0.07--0.71)0.01−1−1−1Comorbidities, n (%) Neurological disorder0.40 (0.17--0.94)0.04−1−1−1 Diabetes mellitus2.43 (1.19--4.96)0.02111C-reactive protein \>100 mg/L at bacteremia onset7.98 (3.76--16.94)\<0.001111[^2][^3]

Performance of Prediction Rule {#S0003-S2003}
------------------------------

According to the odds ratios of these independent predictors recognized in [Table 2](#T0002){ref-type="table"}, the score of each risk predictor was assigned, and three scoring algorithms that corresponded to community-onset *K. pneumoniae* abscesses score (CoKPAS) models 1, 2, and 3 were developed. The score for model 1 included +1 point for each of five positive predictors (ie, male sex, the HMV phenotype, the capsular K1 serotype, comorbid diabetes mellitus and the high CRP level) and −1 point for each of two negative predictors (ie, recent chemotherapy and neurological disorders). To emphasize the importance of HMV, model 2 was modified from model 1 by assigning 0 points to the capsular serotype K1, and model 3 was furtherly modified by additionally assigning 0 points to the HMV phenotype.

The ROC curve of CoKPAS model 1 ([Figure 3](#F0003){ref-type="fig"}) demonstrated a good ability in predicting abscess occurrences, with an area under the curve of 0.83. However, the prediction ability of models 2 and 3 was inferior to that of model 1, with areas under the ROC curve of 0.80 and 0.77, respectively. In CoKPAS model 1, the performance of the prediction model for abscess occurrences in adults with community-onset *K. pneumoniae* bacteremia, including sensitivity, specificity, predictive values, and likelihood ratio, was shown in [Table 3](#T0003){ref-type="table"}. Various cut-off points, ranging from 2 to 4, were used. With higher cut-off points, the sensitivity rates decreased and specificity rates increased. Maximum sensitivity rate, 93.7%, was observed at the lowest cut-off point (total score = 2); and maximum specificity rate (96.6%) at the highest cut-off point (total score = 4).Table 3The Sensitivity, Specificity, Predictive Value, and Likelihood Ratio of the CoKPBAS (Model 1) for Abscess Occurrences in Various Cut-Off PointsCut-Off PointsCase Number with Abscess (%)Sensitivity (%)Specificity (%)Predictive Value (%)Likelihood Ratio (%)PositiveNegativePositiveNegative429 (82.9)36.796.682.977.610.790.66353 (60.9)67.181.060.984.83.530.41274 (45.7)93.750.845.794.81.900.12[^4] Figure 3Receiver operating characteristic curves of three models of *K. pneumoniae* abscess scoring to predict abscess formation in community-onset monomicrobial *K. pneumoniae* bacteremia. The area under the ROC curve is 0.83 (95% confidence interval \[CI\], 0.77--0.88; *P*\<0.001) in model 1, 0.80 (95% CI, 0.74--0.86; *P*\<0.001) in model 2, and 0.77 (95% CI, 0.71--0.83; *P*\<0.001) in model 3.

Clinical Characteristics and Outcomes in Bacteremic Patients with and Without Abscesses {#S0003-S2004}
---------------------------------------------------------------------------------------

A greater proportion of patients in the abscess group had hepatobiliary tract infections, skin and soft-tissue infections, multiple portals of entry, and long lengths of hospital stays. Meanwhile, fewer patients in the abscess group had respiratory tract infections, urinary tract infections, intra-abdominal infections, primary bacteremia, an appropriate antibiotic delay \>3 days, and examination by abdominal sonography using univariate analyses ([Table 4](#T0004){ref-type="table"}). Of note, the proportions of chest X-rays and abdominal CT scans as well as the period between ED triage and imaging studies were similar between the two groups. In addition, the 14-day and 28-day mortality rates and the crude mortality rate at discharge were low in patients in the abscess group.Table 4Infection Sources, Clinical Management, and Outcome of Adults with Community-Onset Monomicrobial *K. pneumoniae* Bacteremia, Categorized by the Presence or Absence of Abscesses^a^CharacteristicsPatient Number (%)*P* valuesAbscess, n=79Non-Abscess, n=179Major Sources of Bacteremia^b^ Hepatobiliary tracts52 (65.8)29 (16.2)\<0.001 Respiratory tracts8 (10.1)48 (26.8)0.003 Skin and soft-tissue8 (10.1)1 (0.6)\<0.001 Urinary tract7 (8.9)42 (23.5)0.006 Bone and joint3 (3.8)3 (1.7)0.37 Intra-abdominal2 (2.5)23 (12.8)0.01 Primary bacteremia0 (0)30 (16.8)\<0.001 Vascular catheter-related0 (0)6 (3.4)0.18 Central nervous systems0 (0)2 (1.1)1.00Antibiotic Therapy Inappropriate administration during ED stay3 (3.8)16 (8.9)0.15 Appropriate administration delay ≥3 days0 (0)13 (7.3)0.01 Appropriate administration delay ≥5 days0 (0)8 (4.5)0.11Multiple portals of entry18 (22.8)4 (2.2)\<0.001Image Studies Chest X-ray79 (100)179 (100)1.00 Abdominal sonography45 (57.0)142 (79.3)\<0.001 Abdominal CT scan68 (86.1)140 (78.2)0.14Periods Between ED Arrival and Image Study (Hours), Mean ± SD Chest X-ray2.0 ± 1.31.8 ± 1.20.38 Abdominal sonography39.6 ± 91.645.6 ± 75.90.66 Abdominal CT scan59.4 ± 98.171.2 ± 107.10.46Lengths of Hospital Stay (Days), Mean ± SD Total hospitalization20.2 ± 13.713.7 ± 14.90.001 Intensive Care Units2.7 ± 7.13.8 ± 12.10.46Clinical Outcomes 14-day mortality4 (5.1)33 (18.4)0.005 28-day mortality8 (10.1)43 (24.0)0.01 Mortality at discharge9 (11.4)47 (26.3)0.008[^5][^6]

Predictors of 28-Day Mortality {#S0003-S2005}
------------------------------

The predictor of 28-day mortality recognized by the univariate analysis included nursing-home residents, the critical illness (Pitt bacteremia score ≥ 4) at bacteremia onset, delayed administration of appropriate antimicrobials ≥3 days, bacteremic pneumonia, bacteremia due to urinary tract infections, fatal comorbidities (McCabe classification), and comorbidities of diabetes mellitus. However, the adverse impact of the HMV phenotype, capsular K1 serotype, and *rmp*A-harboring isolate on 28-day mortality was not significant. When significant predictors recognized by the univariate analysis and HMV factors were together processing under the model of hierarchical logistic regression ([Table 5](#T0005){ref-type="table"}), independent predictors of 28-day mortality only included the critical illness at bacteremia onset, delayed administration of appropriate antimicrobials ≥3 days, bacteremic pneumonia, and fatal comorbidities. Notably, HMV factors, in terms of the HMV phenotype, capsular K1 serotype, and *rmp*A-harboring isolate, remained not a significant determinant of 28-day mortality in the multivariate analysis.Table 5Hypermucoviscosity and Risk Factors of 28-Day Crude MortalityVariablePatient Number (%)Univariate AnalysisMultivariate AnalysisDeath\
n=51Survival, n=207OR (95% CI)P valueAdjusted OR (95% CI)P valueNursing-home residents5 (9.8)6 (2.9)3.64 (1.07--12.45)0.041.22 (0.22--6.83)0.82HMV phenotype19 (37.3)91 (44.0)0.76 (0.40--1.42)0.390.82 (0.29--2.34)0.72Capsular K1 serotype (*mag*A-harboring isolates)11 (21.6)62 (30.0)0.64 (0.31--1.34)0.230.83 (0.30--2.34)0.71*RmpA*-harboring isolates31 (60.8)131 (63.3)0.90 (0.48--1.69)0.741.10 (0.34--3.56)0.87Pitt bacteremia score ≥4 points at onset35 (68.6)31 (15.0)12.42 (6.14--25.11)\<0.0018.98 (3.80--21.24)\<0.001Delayed administration of appropriate antimicrobials ≥3 days7 (13.7)6 (2.9)5.33 (1.71--16.63)0.0026.85 (1.23--37.99)0.03Sources of Bacteremia Pneumonia30 (58.8)29 (14.0)8.77 (4.43--17.34)\<0.0015.81 (2.46--13.73)\<0.001 Urinary tract infections3 (5.9)48 (23.2)0.21 (0.06--0.69)0.0050.39 (0.09--1.65)0.20Fatal comorbidities (McCabe classification)27 (52.9)49 (23.7)3.63 (1.92--6.86)\<0.0015.05 (2.09--12.22)\<0.001Comorbid diabetes mellitus15 (29.4)94 (45.4)0.50 (0.26--0.97)0.040.37 (0.15--1.02)0.06[^7]

Although the adverse impacts of abscess occurrences on 28-day mortality (odds ratio \[OR\], 0.36; *P* = 0.01) was recognized in the univariate analysis ([[supplemental Table](https://www.dovepress.com/get_supplementary_file.php?f=240809.docx)]{.ul}), the association of abscess occurrences and 28-day mortality was not evidenced (Adjusted OR, 0.73; *P* = 0.53) in the multivariate analysis, after adjusting the following independent determinates of 28-day mortality: the critical illness at bacteremia onset, delayed administration of appropriate antimicrobials ≥3 days, bacteremic pneumonia, and fatal comorbidities.

Discussion {#S0004}
==========

To achieve better prognoses of patients with the invasive syndrome caused by hypermucoviscous *K. pneumoniae*, adequate and rapid drainage or surgery for the abscess complication is recommended.[@CIT0006] Additionally, timely and aggressive antimicrobial administration has been suggested, eg, a third-generation cephalosporin is preferable to a first-generation cephalosporin.[@CIT0022] Therefore, the scoring algorithm proposed in this study could assist clinicians in providing timely imaging studies, surgical or drainage intervention, and prescriptions of third-generation cephalosporin. The use of this algorithm may also reduce costs by reducing the usage of expensive imaging studies and avoiding unnecessary kidney injuries caused by contrast medium in those who are not truly at the high risk for the abscess occurrence.

In the past, a new, hypervirulent or hypermucoviscous variant of *K. pneumoniae* has slowly emerged worldwide. However, new evidence has indicated that HMV and hypervirulence are two different phenotypes that should not be used synonymously.[@CIT0007] Hypervirulence genes detected in *K. pneumoniae* included *p-rmpA, iroB, iucA*, and *iutA*.[@CIT0023] On the other hand, the specific genotype, primarily *rmp*A, and the capsular serotype K1/K2 were proposed to be defining characteristics of hypermucoviscous *K. pneumoniae*.[@CIT0007],[@CIT0009] More importantly, the K1 serotype was the most prevalent one in the Far Eastern region.[@CIT0007] Accordingly, in addition to clinical information and the HMV phenotype, capsular serotype K1 and *rmp*A were selected as the eligible component constituted to the simple scoring algorithm in predicting the abscess occurrence herein. Furthermore, all the HMV factors were irrespective of short-term prognoses and thus it is reasonable to believe that these factors were not contributory to predict patient outcomes, as shown in [Table 5](#T0005){ref-type="table"}.

In this study, the importance of the HMV phenotype, *mag*A and *rmp*A was emphasized in regards to the occurrence of abscesses, especially hepatic abscesses, among adults with community-onset *K. pneumoniae* bacteremia. Thus, it was reasonable that we integrated these HMV-related variables to propose a scoring algorithm that was accurate for the early identification of patients at high risk for abscesses. In combination with other clinical parameters that were available immediately at the ED arrival, the ROC of the scoring system proposed that using this simple clinical scoring algorithm has substantial sensitivity and satisfactory specificity. Moreover, based on differences in the areas under the ROC curves of models 1, 2, and 3, the importance of the HMV phenotype and the mucoviscosity-associated *mag*A genes (ie, capsular serotype K1) was also demonstrated. Notably, the relationship between abscess formation and the capsular serotype K1 was strengthened in the current study. This finding was in line with previous reports,[@CIT0015] which indicated the capsular K1 serotype had a strong relationship with primary liver abscesses and hepatic metastatic infections that were secondary to hepatic abscesses.[@CIT0005],[@CIT0015] However, CoKPAS model 2, which did not include the capsular K1serotype, retained an acceptable prediction capability for abscess formation. Thus, even in a laboratory lacking routine detection of K1 isolates, this modified model retains an acceptable prediction capability.

There are several limitations inherent to the design of this study. First, despite numerous exclusion criteria in our study design, only little proportions (27/287, 9.4%) of the entire cohort were excluded. Therefore, the selection basis should be trivial. Second, not all patients without abscesses underwent abdominal CT examination herein. To avoid misclassification for the abscess categorization, patients in the non-abscess group were designed to follow patients for a long period after bacteremia onset to confirm that no recurrence of *K. pneumoniae* bacteremia or abscesses took place. Consequently, only one patient was excluded from our analyses because of incomplete information; therefore, the misclassification basis should be neglected. Third, because the study population was focusing on one-center adults, a lack of an independent validation is one of the study limitations, and the predictability of this algorithm may not be extended to other populations with varied infection sources and bacteremia severity. Finally, because the incidence of abscess occurrences and prevalence of HMV highly varied in different communities, three cut-off values were offered for clinicians. In a region with a high incidence, the cut-off value of +2 is appropriate to achieve the high sensitivity. However, a well-designed, multinational study is warranted to externally validate the clinical significance of this scoring system.

Conclusively, to rapidly recognize the occurrence of abscesses, a simple scoring algorithm that has substantial sensitivity and satisfactory specificity in adults with community-onset *K. pneumoniae* bacteremia was proposed. For hospitals lacking routine detection of the capsular K1 serotype, the modified model, which only uses the HMV phenotype combined with five clinical predictors, retains an acceptable prediction capability. An imaging study may also be recommended for patients with a CoKPAS score ≥2. However, the cost-effectiveness of this algorithm should be investigated in the future to assess its clinical utility.
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[^1]: **Note:** ^a^Not all patients had the indicated laboratory data.

[^2]: **Notes:** ^a^Exclusion of variable with *mag*A. ^b^Exclusion of variables with *mag*A and hypermucoviscosity phenotype.

[^3]: **Abbreviations:** CoKPBAS, community-onset *K. pneumoniae* bacteremia abscess score; HMV, hypermucoviscosity; OR, odds ratio.

[^4]: **Abbreviations:** CoKPBAS, community-onset *K. pneumoniae* bacteremia abscess score.

[^5]: **Notes:** ^a^Data are expressed as case numbers (percentages), unless specifically indicated. ^b^Indicates the type of abscesses in patients in the abscess group.

[^6]: **Abbreviations:** ED, emergency department; CT, computed tomography; SD, standard deviation.

[^7]: **Abbreviations:** HMV, hypermucoviscosity; CI, confidence interval; OR, odds ratio.
